Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications. - Wikidata - awgldk - TriplyDB

Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.

Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.

http://www.wikidata.org/entity/Q35058030

about

Baculovirus-mediated gene delivery into Mammalian cells does not alter their transcriptional and differentiating potential but is accompanied by early viral gene expression.Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population CYP2B6 non-coding variation associated with smoking cessation is also associated with differences in allelic expression, splicing, and nicotine metabolism independent of common amino-acid changes Effect of Cytochrome b5 Content on the Activity of Polymorphic CYP1A2, 2B6, and 2E1 in Human Liver Microsomes Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation CYP2B6rs2279343 Is Associated with Improved Survival of Pediatric Rhabdomyosarcoma Treated with Cyclophosphamide Structural features of cytochromes P450 and ligands that affect drug metabolism as revealed by X-ray crystallography and NMR.Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals.Baculovirus-mediated gene transfer and recombinant protein expression do not interfere with insulin dependent phosphorylation of PKB/Akt in human SHSY-5Y and C3A cells Effects of fetal bovine serum deprivation in cell cultures on the production of Anticarsia gemmatalis multinucleopolyhedrovirus.Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?Baculovirus as versatile vectors for protein expression in insect and mammalian cells.Effect of Host Genetic Variation on the Pharmacokinetics and Clinical Response of Non-nucleoside Reverse Transcriptase Inhibitors.Genetic factors affecting drug disposition in Asian cancer patients.The baculovirus GP64 protein mediates highly stable infectivity of a human respiratory syncytial virus lacking its homologous transmembrane glycoproteins Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes.Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites Sarcomas and pharmacogenetics.Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.Compensatory changes in CYP expression in three different toxicology mouse models: CAR-null, Cyp3a-null, and Cyp2b9/10/13-null mice Antimycotic drug discovery in the age of genomics.Allele and genotype frequencies of CYP2B6 and CYP2C19 polymorphisms in Egyptian agricultural workers.The role of genetic variability in drug metabolism pathways in breast cancer prognosis.Genetic markers in CYP2C19 and CYP2B6 for prediction of cyclophosphamide's 4-hydroxylation, efficacy and side effects in Chinese patients with systemic lupus erythematosus.Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance.Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver.Interindividual variability of methadone response: impact of genetic polymorphism.RING and coiled-coil domains of baculovirus IE2 are critical in strong activation of the cytomegalovirus major immediate-early promoter in mammalian cells.Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?Induction of antitumor immunity against mouse carcinoma by baculovirus-infected dendritic cells.Personalized medicine in oncology: tailoring the right drug to the right patient.Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation.Cytochrome P450 pharmacogenetics in African populations.Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda.Use of human in vitro skin models for accurate and ethical risk assessment: metabolic considerations.

P2860

Q24543324-1C89C30A-D381-4C23-B022-752C8204E222 Q24676890-5C510090-6125-4D62-B631-190A1D1DA2C7 Q26798470-F68BA5B9-A2D0-496D-A6F5-A2621A131DDD Q28083875-3B4BFA45-E046-46B4-BE50-9CDC4D3DE72B Q28535164-DAC08662-07A3-48AE-96F8-A4D396DC6ACB Q28547950-30C19681-A447-4EA3-9251-95913A266166 Q28550763-0BDB7DD4-1C09-4B4F-A370-519AA5FD10D5 Q28552450-87459B83-0FA9-44B5-A38A-B779C02FA891 Q30396630-623B82F1-43D5-464C-AB92-87AF970B683D Q33246815-EC1F3E60-34D8-417F-A712-5AF9B9A5C37F Q33269667-39F5DD1D-60FA-409A-A746-936FE2A11687 Q33274596-CA9EDE79-6CC3-4A68-BC22-A4A44EF44153 Q33693328-58B3079C-41C7-4859-84F4-494C07FA3E5F Q33747406-B2BE0E5F-0983-4BDB-9631-D90184E4E8A5 Q34307873-01F4C34E-6F44-4BC0-83FD-336A05808DE2 Q34416430-EE67DC62-BD60-4D00-86FA-F23504EFF50E Q34443184-F39421D1-D42B-4156-960F-F58064127A66 Q34501025-7BD6466A-29F6-4328-AB31-67A1005893EF Q34553841-A69D11CC-2DB6-4CF8-959C-516D03796479 Q35718630-9F5C0050-08AF-4448-A32A-8ED40F17B21F Q36024598-71DFA503-E439-4C5E-AE8F-26607F6314A4 Q36249224-A71C14D3-B55E-4B51-93DE-3C71F2A29125 Q36305439-0C3B44BB-FE5A-4E04-A100-D950B039B6EC Q36325362-52C5BD4B-3690-4886-AFD2-CB877AC7F522 Q36334753-EE92FB6F-F269-4F26-9D67-B7303C34D45A Q36406247-9E84190A-FC90-46FA-8A0E-C861A3091758 Q36497088-FE4EB91B-FD12-4211-A4A5-72F0E5A89DA9 Q36802054-0968C1E8-7CCD-482D-B1D6-C61DC6550FD2 Q36885659-0FA2EC11-AE6E-4054-A7E0-85FBEFFFF4A2 Q36909743-5F3B011A-AF13-48B4-B38D-A6BE92237EAB Q37142009-6021E3BE-4CB5-4C69-B0E0-CB707FB7A79D Q37145287-08F87612-78A0-415F-BB5D-1C2D15180696 Q37169244-F71BB533-C796-4F36-B559-B699CF61A81C Q37271799-61C934FF-A560-4207-B8D2-5E7ED38E2C4C Q37729202-402A3424-250F-4A0D-92EB-BC2E5A440895 Q37779306-326B58F4-20C2-486C-8F37-2D80BCEB2122 Q38068541-655322FE-0C25-4312-9D4A-B2B7463912B6 Q38099372-DFED365A-3FF2-4B3A-9EDA-28576196FACC Q38878356-29D425C4-237B-492D-AE1C-1CE86B566267 Q39173876-F22AF796-C3AD-4A89-A74A-D0E728A4932F

P2860

Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.

http://www.wikidata.org/entity/Q35058030

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

name

Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.

@ast

Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.

@en

type

label

Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.

@ast

Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.

@en

prefLabel

Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.

@ast

Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.

@en

P1433

Q35058030-5F7CC263-F44B-42D3-AED8-C9EC2F8A1027

P1476

Q35058030-7C0A0D0F-640A-4BA2-B7B5-77632200B276

P2093

Q35058030-3D460A73-9A98-4F7A-B2F1-D08BF09F92F0

Q35058030-A74CDF6C-68D6-44CE-9450-F121A188AFDA

P2860

Q35058030-08799412-9E86-437F-8EC0-04F1A956090B

Q35058030-10DDC9CF-CD04-4A46-8549-B14FE80B208A

Q35058030-2B4710AF-E0F8-4520-BC88-519E455F9766

Q35058030-34AC2D15-9B1D-4FEE-88D1-9BA61B9D3CEC

Q35058030-54CA6081-F6FA-417A-A3E2-35A0FC987894

Q35058030-61D9C0A7-BEE5-4619-9167-778D9E8EC437

Q35058030-6D7E0161-3B6F-4C9F-870C-904C59E44E02

Q35058030-72B599DF-C0AF-4B0E-B9D8-60D0CF0A2E7C

Q35058030-96F18501-E55C-4C4C-A44D-52A27BB06E7A

Q35058030-9A5A1330-8277-434D-A8E0-6E62CCEA1B11

P2888

Q35058030-9AD116F9-6D4F-4459-B0EC-8FF8672E65DB

P304

Q35058030-E97A1A28-AE1B-42EE-9EC8-011EEB3AEB67

P31

Q35058030-0A297614-D1CC-4728-A8E7-11726279CC45

P356

Q35058030-3CA3E957-5176-4AD6-BF1B-28B67D169DE5

P433

Q35058030-ADD08334-DCD7-432A-B297-ABF7020ACFA5

P478

Q35058030-221DF5A9-7498-45B6-93B3-14AF3D099FC9

P577

Q35058030-4A6AB94E-C190-4BCE-8E4F-D5C23FAF64FD

P5875

Q35058030-51865763-76B2-46A3-AAB4-3C68C1273DAC

P698

Q35058030-BF3767AE-069C-4366-98C4-79603DE3BE87

Q35058030-e9dcc573-84c9-47f4-9c2e-21384a13019b

P356

P1433

Molecular Diagnosis and Therapy

P1476

Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.

@en

P2093

Andreas Hüser

http://www.w3.org/2001/XMLSchema#string

Christian Hofmann

http://www.w3.org/2001/XMLSchema#string

P2860

3'-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures.

The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene

Involvement of human liver cytochrome P4502B6 in the metabolism of propofol

A single nucleotide polymorphism of CYP2b6 found in Japanese enhances catalytic activity by autoactivation.

The role of CYP2B6 in human xenobiotic metabolism.

cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver.

A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients.

Metabolism of oxazaphosphorines.

Investigation of the major human hepatic cytochrome P450 involved in 4-hydroxylation and N-dechloroethylation of trofosfamide.

Inhibitory monoclonal antibody to human cytochrome P450 2B6.

P2888

P304

53-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.TPJ.6500157

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10862027

http://www.w3.org/2001/XMLSchema#string

P698

12562216

http://www.w3.org/2001/XMLSchema#string